Pier 88 Investment Partners LLC Sage Therapeutics, Inc. Transaction History

Pier 88 Investment Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $296,687 - $763,016	-4,930 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $115,739 - $156,717	825 Added 20.1%	4,930 $692,000
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $144,714 - $265,113	1,620 Added 65.19%	4,105 $653,000
Q4 2018 Feb 11, 2019	SELL	$81.94 - $139.71 $142,165 - $242,396	-1,735 Reduced 41.11%	2,485 $238,000
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $343,203 - $420,064	2,485 Added 143.23%	4,220 $596,000
Q2 2018 Jul 25, 2018	BUY	$140.36 - $175.76 $243,524 - $304,943	1,735 New	1,735 $272,000

195

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $437M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Pier 88 Investment Partners LLC with notifications on news.